Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
CA 2302284 A1 · Owner: Menta, Ernesto · Inventors: Menta, Ernesto; Zimmermann, Gerd; Conti, Marco
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Subject of the present invention are compounds of general formula (I) wherein , A is oxygen or sulfur; X is oxygen or sulfur; R1 and R2 are independently hydrogen or an alkyl group with from 1 to 6 carbon atoms; R is selected from alkyl, cycloalkyl, alkylsulphinyl, alkylsulphonyl hydroxyalkyl, napthtyl, phenyl group which can be unsubsituted or substituted; or R is a 5- or 6membered heterocycle containing from 1 to 3 heteroatoms selected from oxygen sulfur and nitrogen, which can be optionally benzocondensed the pure , steroisomers or mixtures thereof as well as salts thereof with pharmaceutically acceptable acids or bases for the use as medicaments, in , particular as antitumor agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 1, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.